Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Syndicated Content about Biotechnology, Pharmaceutical and Healthcare

15:17 EDT 30th July 2014 | BioPortfolio

Latest global life science, pharmaceutical and healthcare news syndicated from over 50 publishers. 

Showing News Articles 1–25 of 350,000+

Wednesday 30th July 2014

UPDATE 1-Liberia shuts schools, quarantines communities in bid to halt Ebola

* Security forces ordered to impose new strict measures in Liberia

Dissolvable fabric loaded with medicine might offer protection against HIV

Soon, protection from HIV infection could be as simple as inserting a medicated, disappearing fabric minutes before having sex.

Lorillard e-cigarette sales slip as competition rises

(Reuters) - Lorillard Inc. on Wednesday reported significant declines in its electronic cigarettes sales, raising questions about the strength of the nascent market.

Liberia shuts schools, quarantines communities in bid to halt Ebola

DAKAR, July 30 (Reuters) - Liberia announced on Wednesday the closure of all schools across the country and the quarantine of a number of communities in a bid to halt the worst Ebola outbreak on record spreading across West Africa.

More in New York, New Jersey infected with chikungunya: CDC

(Reuters) - Cases of chikungunya virus, a painful, mosquito-borne disease that has spread rapidly through the Caribbean in recent months, spiked higher in New York and New Jersey in the past week, according to new federal data.

Germany appoints new head of BfArM from within the ranks

Professor Karl Broich is to take over as chair of the German medicines regulator BfArM effective 6 August. Professor Broich, who is currently vice-chair of the agency, succeeds Professor Walter Schwerdtfeger, who is retiring at the end of July.

U.S. doctor, missionary with Ebola show improvement

WINSTON-SALEM N.C. (Reuters) - Two American aid workers infected with Ebola in Africa while responding to an outbreak of the deadly virus have shown slight improvement but remain in serious condition, a relief organization said on Wednesday.

Suspected Ebola cases sent home as Liberian isolation unit fills up

* Existing unit in Monrovia overflowing, new ward delayed by protests

UPDATE 1-Sanofi, Regeneron cholesterol drug may cut heart risk, trial hints

(Adds CEO comments, details on reduced heart risk, drug background)

UPDATE 3-Care center closures boost Amedisys profit, shares jump

* 2nd-qtr adjusted net income attributable to company rises to $8 mln

Pfizer spends $635 million on acquiring two Baxter vaccines

US pharma giant Pfizer has entered into a definitive agreement to acquire Baxter International portfolio of marketed vaccines for $635 million.

Boston Scientific wins first trial over transvaginal mesh device

(Reuters) - A Massachusetts jury has cleared Boston Scientific Corp of selling dangerous and defective transvaginal mesh devices, in the first out of more than 20,000 lawsuits waiting to go to trial.

Regeneron’s Eylea gains FDA approval for DME

The Food and Drug Administration has approved US biotech firm Regeneron Pharmaceuticals’ Eylea (aflibercept) injection for the treatment of diabetic macular edema (DME).

New indications approved in EU for Bristol-Myers/Pfizer Eliquis

The European Commission has approved US pharma majors Bristol-Myers Squibb and Pfizer’s Eliquis (apixaban) for the additional indications of the treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and the prevention of recurrent DV...

Charterhouse hires Goldman Sachs for sale of UK skincare firm Deb - source

LONDON, July 30 (Reuters) - European private equity fund Charterhouse has hired Goldman Sachs to sell UK skincare firm Deb, a source familiar with the matter said on Wednesday.

Durata out-licenses dalbavancin to Angelini for certain territories

USA-based Durata Therapeutics says its Dutch subsidiary entered into a license and supply agreement with privately-held Italian drugmaker Angelini, to commercialize dalbavancin in 36 countries, which include Italy, Spain, Poland, Portugal, many Easte...

A smart wristband for nocturnal cyclists

In large cities it can be difficult for cyclists to brave traffic with confidence. This is the case particularly at night, when it comes to changing lanes in the middle of motorists. Based on this reality, five doctoral students of the Electronics La...

Possible treatment for kidney disease in lupus

In the U.S. alone, more than 1.5 million people have lupus, a chronic autoimmune disease in which the immune system turns against itself, attacking a person’s healthy tissue, cells and organs. The symptoms can range from debilitating pain and f...

Infusions of young blood may reverse effects of ageing, studies suggest

Giving old mice young blood reversed age-related declines in brain function, muscle strength and stamina, researchers say Blood transfusions rejuvenate mice. Could they do the same for humans? Researchers in the US are closing in on a therapy that co...

Cellectis sells Swedish subsidiary to Japan’s Takara Bio

France-based genome engineering specialist Cellectis says it has sold its Swedish subsidiary Cellectis AB to the Japanese company Takara Bio.

Discovery of protein's role in making platelets may aid multiple myeloma patients

A University of Utah School of Medicine-led study has identified a previously unknown but crucial component in the process to make platelets, a discovery that could help spare multiple myeloma patients from a dangerous side effect of the primary drug...

Saving seeds the right way can save the world’s plants

Exotic pests, shrinking ranges and a changing climate threaten some of the world's most rare and ecologically important plants, and so conservationists establish seed collections to save the seeds in banks or botanical gardens in hopes of preserving...

Climate change research goes to the extremes

Read more about Climate change research goes to the extremesComments

All-in-one energy system offers greener power for off-grid buildings

An innovative “trigeneration” system fuelled entirely by raw plant oils could have great potential for isolated homes and businesses operating outside grid systems both in the U.K. and abroad.Read more about All-in-one energy system offers greene...

Remarkable Twin Study Widens View of Down’s Syndrome

A large coalition of European and American researchers this week published a new gene expression study of trisomy 21, better known as Down’s syndrome, using a novel cellular model of the disorder. Induced pluripotent stem cells were derived fro...


Search BioPortfolio: